Solid Tumor Cancer Clinical Trials

34 recruitingLast updated: June 17, 2026

There are 34 actively recruiting solid tumor cancer clinical trials across 12 countries. Studies span Phase 1, Phase 2, Not Applicable. Top locations include Shanghai, Shanghai Municipality, China, New York, New York, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


Solid Tumor Cancer Trials at a Glance

34 actively recruiting trials for solid tumor cancer are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Phase 1 with 22 trials, with the heaviest enrollment activity in Shanghai, New York, and Houston. Lead sponsors running solid tumor cancer studies include Avenzo Therapeutics, Inc., HC Biopharma Inc., and BioNTech SE.

Browse solid tumor cancer trials by phase

Treatments under study

About Solid Tumor Cancer Clinical Trials

Looking for clinical trials for Solid Tumor Cancer? There are currently 25 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Solid Tumor Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Solid Tumor Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 34 trials

Recruiting
Not Applicable

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

Advanced Solid Tumor CancerGlioblastomaSmall Cell Lung Cancer Extensive Stage+2 more
University of Colorado, Boulder250 enrolled2 locationsNCT07636200
Recruiting
Phase 1

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Advanced Solid Tumor Cancer
Calico Life Sciences LLC248 enrolled30 locationsNCT04777994
Recruiting
Phase 1Phase 2

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

ParagangliomaPheochromocytomaSolid Tumor Cancer+19 more
Fundación de investigación HM25 enrolled1 locationNCT06607692
Recruiting
Phase 1Phase 2

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Urothelial CancerLocally AdvancedSolid Tumor Cancer+1 more
Avenzo Therapeutics, Inc.355 enrolled10 locationsNCT07193511
Recruiting
Not Applicable

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III+4 more
Fred Hutchinson Cancer Center100 enrolled1 locationNCT06802172
Recruiting
Phase 1

QLS5212 for Participants With Advanced Solid Tumors

Solid Tumor Cancer
Qilu Pharmaceutical Co., Ltd.100 enrolled1 locationNCT07467629
Recruiting
Phase 1Phase 2

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

Advanced Solid Tumor Cancer
BioNTech SE533 enrolled5 locationsNCT07455734
Recruiting
Phase 1Phase 2

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Lung CancersUrothelial CancerLocally Advanced+5 more
Avenzo Therapeutics, Inc.480 enrolled18 locationsNCT07038343
Recruiting
Phase 1

Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors

Solid Tumor CancerSolid Tumor Cancer Treatment With Immunotherapy
Jun Zhou90 enrolled6 locationsNCT07584954
Recruiting
Phase 1

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

Breast CancerOvarian CancerCancer+4 more
Conjupro Biotherapeutics, Inc.386 enrolled5 locationsNCT07424547
Recruiting
Not Applicable

A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor

TreatmentSolid Tumor CancerVaccine+1 more
Fudan University9 enrolled1 locationNCT06682117
Recruiting
Phase 1

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

Advanced Solid Tumor Cancer
HC Biopharma Inc.331 enrolled1 locationNCT07477743
Recruiting
Phase 1Phase 2

IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors

Solid Tumor CancerPDAC
InxMed (Shanghai) Co., Ltd.92 enrolled14 locationsNCT07441174
Recruiting

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Breast CancerEsophageal CancerProstate Cancer+10 more
Washington University School of Medicine100 enrolled1 locationNCT04354064
Recruiting
Phase 1

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

Solid Tumor CancerAdvanced Malignant Solid Tumor
Pilatus Biosciences Inc36 enrolled2 locationsNCT07337525
Recruiting
Not Applicable

Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application

ChemotherapyCancerSolid Tumor Cancer
University of Pittsburgh50 enrolled1 locationNCT07218874
Recruiting
Phase 1

X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma

Advanced Solid Tumor Cancer
Immunolight, LLC52 enrolled4 locationsNCT04389281
Recruiting
Phase 2

Phase II Study of LM-24C5

Advanced Solid Tumor Cancer
LaNova Medicines Limited130 enrolled2 locationsNCT07387081
Recruiting
Phase 1

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

Advanced Solid Tumor Cancer
HC Biopharma Inc.328 enrolled1 locationNCT07381829
Recruiting
Phase 2

Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies

Antibody-drug ConjugatesAdvanced Solid Tumor CancerUrachal Cancer
Sheng Zhang90 enrolled1 locationNCT07309770